Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Four Potential Acquisition Targets for Big Pharma
https://technical420.com/cannabis-article/cannabis-biotech-sector-ripe-prime-acquisition-targets-big-pharma
No 2 VNNYF: Earlier this month, Vinergy Resources (VNNYF) signed a definitive agreement to complete the acquisition of MJ BioPharma, a private cannabis technology company focused on manufacturing breath strips, time release capsules, extract oils, food products, and pharmaceutical grade delivery systems. MJ Biopharma will also aim to in-license and joint venture on technologies and products for global medical and recreational cannabis industry.
Top 3 Marijuana Stocks Canada Wants To Keep To Themselves
Canadian Biotech Breaks Out of Oversold Territory and Set to Rally
Vinergy (VNNYF) traded almost 900,000 shares on Friday and VNNYF rallied well off its lows of the day. We think this massive increase in trading volume is significant and the shares no longer in oversold territory.
We see significant upside to current levels as VIN (the Canadian symbol) remains halted due to closing of the MJ Biopharma deal. Vinergy recently announced that it was increasing the size of its non-brokered private placement due to the high demand and this is a stock investors need to have on their radar
Almost 900k volume Friday... This is the time to buy if you required a signal
LOL this has to be the dumbest thing I've ever read, great job Jarrod !! LOL
FROM BS ARTICLE
(The company will pay for MJ by issuing 9,750,000 common shares at a price of CDN$0.20. The merger contract includes some insignificant conditions that we don’t believe could break the deal; these include a finder’s fee of 400,000 common shares, the CSE approval, and some other customary conditions that were not highlighted in the press release.''
Share dilution
The first thing that we did not appreciate in the merger agreement is that the company is issuing shares to acquire MJ. This has been quite bad for previous shareholders and explains the recent decline in the share price)
REAL INFORMATION : Incentivized Compensation Plan
Perhaps the most exciting piece of this acquisition is the means in which Vinergy is acquiring MJ Biopharma. 4.25M shares of common stock priced at $0.20CAD are to be issued upfront, 2/3 of which will be held in escrow. But MJ Biopharma management and shareholders have the opportunity to earn an additional 5M shares is they bring each of their 4 product segments to commercialization. This is a genius move by VNNYF management that could drastically increase shareholder value down the road.
FROM BS ARTICLE
Savvy traders surely noticed that this last announcement is tricky. The company has issued800,000 units of stock and warrants. As the warrants are exercisable to obtain another one, the total potential dilution is 1.6 million new shares. According to OTC Markets, the company has approximately 36 million share outstanding, thus previous shareholders lost about 4.4% in this transaction.
REAL INFORMATION
Financing is done at 100% higher than yesterday's close is clearly not a bad sign. Someone willing to pay a 100% premium to buy a significant ownership in the Company should be rather welcomed. Clearly we need this financing to be announced closed.
FROM BS ARTICLE
The balance sheet doesn’t look good
We found the latest balance sheet, which reveals that the financial situation is not optimal. As of November 30, 2016, the company showed the following accounts:
Loans receivable: CAD$29,400
Advances to operator: CAD$13,546
Total Assets: CAD$46,936
Convertible debentures: CAD$215,000
Due to related parties: CAD$490,913
Total liabilities: CAD$907,894
REAL INFORMATION
Post this the date suggested by the author, the Company closed a financing of 2M+ dollars and accordingly the balance sheet risk is invalid. In fact the only money they spent aside from their low burn rate of c. 20k a month is 260,000$ to acquire 65% of Health Canada and FDA licensed lab that allows them access to various IP as well formulations that are unique to MJ BioPharma. In turn MJ BioPharma is following a licensing model that allows them to remain lean and continue the low burn rate whilst generating revenue from their royalties.
Overall, this seems like someone who either has a short position against the Company or one that is misinformed.
http://www.marketwired.com/press-release/vinergy-resources-increases-private-placement-to-usd-400000-cse-vin-2216733.htm
Vinergy Resources Increases Private Placement to USD $400,000
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 16, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN)(CSE:VIN.CN)(OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that, due to increased demand, the non-brokered private placement offering announced on May 11, 2017 has been increased to USD $400,000. The Company will now issue up to 800,000 units (the "Units") at a price of USD $0.50 per Unit for gross proceeds of up to USD $400,000 (the "Offering"). Each Unit will consist of one common share in the capital of the Company (a "Share") and one transferable common share purchase warrant (a "Warrant"), with each Warrant exercisable into one additional Share at a price of USD $1.00 for a period of three years from the date of closing (subject to acceleration in certain circumstances).
In connection with the Offering, the Company may pay a finder's fee on the Offering within the amount permitted by the policies of the Canadian Securities Exchange (the "Exchange").
Vinergy Resources Increases Private Placement to USD $400,000 at US50 cent
http://www.otcmarkets.com/stock/VNNYF/news/Vinergy-Resources-Increases-Private-Placement-to-USD--400-000?id=159230&b=y
Cannabis Companies Leveraging Biotech Enhancements to Boost Improved Purity of Medicinal Marijuana Treatments and Products
PALM BEACH, Florida, May 16, 2017 /PRNewswire/ --
The influence of biotech advancements in the cannabis industries continues to be apparent as more and more companies focus upon various aspects of biotechnology to enhance operations and in turn boost revenues. With a growing population and finite natural resources, the challenge to produce higher quality therapies, treatment and increasing the purity of legal marijuana products while protecting the consumer is real while advances in biotechnology are quickly becoming a vital tool to help the legal medical marijuana industry get there. Companies focused on advancing high quality products for the industry include: Vinergy Resources Ltd. (OTC: VNNYF) (CSE: VIN), Terra Tech Corp. (OTC: TRTC), mCig, Inc. (OTC: MCIG), Radient Technologies Inc. (TSX-V: RTI.V), Aurora Cannabis Inc. (OTC: ACBFF) (TSX-V: ACB.V).
Radient Technologies Inc. (TSX-V: RTI.V) (OTC: RDDTF) closed up over 16% at $0.56 on Monday trading over 3.6 Million shares on the Canadian TSX Venture exchange by the market close. Radient Technologies announced yesterday the completion of the second phase of its previously announced joint venture research agreement with Aurora Cannabis Inc. (TSX-V: ACB. V)(OTCQX ACBFF). As previously announced, Radient and Aurora entered into a memorandum of understanding ('MOU') with regard to the exclusive joint development and commercialization of superior and standardized cannabinoid extracts for the Canadian market. In accordance with the MOU, the parties entered into a joint venture research agreement to confirm the effectiveness of Radient's MAP™ technology for cannabis extraction.
Vinergy Resources Ltd. (OTCQB: VNNYF) (CSE: VIN) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that, due to increased demand, the non-brokered private placement offering announced on May 11, 2017 has been increased to USD $400,000. The Company will now issue up to 800,000 units (the 'Units') at a price of USD $0.50 per Unit for gross proceeds of up to USD $400,000 (the 'Offering'). Each Unit will consist of one common share in the capital of the Company (a 'Share') and one transferable common share purchase warrant (a 'Warrant'), with each warrant exercisable into one additional share at a price of USD $1.00 for a period of three years from the date of closing (subject to acceleration in certain circumstances). Read this and more news for Vinergy Resources at:http://www.marketnewsupdates.com/news/vnnyf.html
Vinergy Resources recently announced that it has signed a definitive agreement with 1099955 B.C. LTD. dba MJ BioPharma ('MJ BioPharma') whereby Vinergy will purchase 100% of MJ BioPharma, a cannabis technology company. Pursuant to the terms of the Agreement, the Company will acquire all of the issued and outstanding securities of MJ BioPharma. MJ Biopharma is a cannabis technology company with a team of experienced business and medical professionals, biochemists and researchers.
In conjunction with acquisition of MJ Biopharma, the Company announced it has developed a disruptive solvent-based extraction system. The project currently underway for an existing customer, utilizes an ethanol / CO2 co-solvent blend and specialized equipment to achieve medicinal products with significantly increased purity. The current iteration of the machine has the physical footprint of a standard shipping skid and incorporates safety and process control systems in one easy-to-use platform.
In other industry news and market performance of note in the sector:
Terra Tech Corp. (OTCQX: TRTC) closed up on Monday at $0.197 trading over 2.5 million shares by the market close. Terra Tech Corp last week announced its first quarter 2017 financial results for the period ended March 31, 2017. Derek Peterson, Chief Executive Officer of Terra Tech Corp., commented, "We are pleased to see the impact of our expansion strategy to open cannabis dispensaries in core target markets drive strong sales in the first quarter. We also reported higher sales of our wholesale IVXX-branded cannabis products as a result of its improved brand recognition coupled with expanded distribution channels. Total first quarter revenues were $6.8 million, representing a 340% increase over the prior year period and we are on track to meet our revenue guidance of $38 - $40 million for 2017."
mCig, Inc. (OTCQB: MCIG) closed up over 5% on Monday at $0.2425 trading over 3.4 million shares by the market close. mCig, Inc. yesterday announced some highlights of its year-end financial results: Net Sales increased to $4.5 million, a 158% increase year-to-year comparison, and a 1,294% increase for the 4th quarter compared to same period last fiscal year - Net income of $1.5 million compared to a $1.4 million loss from the previous year, and an increase of $2.9 million net earnings - Cash and cash equivalents of $1.6 million compared to $0.1 million from the previous year (a 1,369% increase), and a 400% increase from last quarter. mCig generated $2.1 million in cash from operating activities - mCig assets increased to $6.8 million, having 6 times more assets than it does liabilities. In addition to the highlights mentioned above, mCig Inc. was able to reduce its operating expenses by $730K (43%) from the previous year. In addition, mCig increased its gross profit by 20% to 36% compared to 16% from the previous year.
Cannabis Companies Leveraging Biotech Enhancements to Boost Improved Purity of Medicinal Marijuana Treatments and Products
PALM BEACH, Florida, May 16, 2017 /PRNewswire/ --
The influence of biotech advancements in the cannabis industries continues to be apparent as more and more companies focus upon various aspects of biotechnology to enhance operations and in turn boost revenues. With a growing population and finite natural resources, the challenge to produce higher quality therapies, treatment and increasing the purity of legal marijuana products while protecting the consumer is real while advances in biotechnology are quickly becoming a vital tool to help the legal medical marijuana industry get there. Companies focused on advancing high quality products for the industry include: Vinergy Resources Ltd. (OTC: VNNYF) (CSE: VIN), Terra Tech Corp. (OTC: TRTC), mCig, Inc. (OTC: MCIG), Radient Technologies Inc. (TSX-V: RTI.V), Aurora Cannabis Inc. (OTC: ACBFF) (TSX-V: ACB.V).
Vinergy Resources Ltd. (OTCQB: VNNYF) (CSE: VIN) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that, due to increased demand, the non-brokered private placement offering announced on May 11, 2017 has been increased to USD $400,000. The Company will now issue up to 800,000 units (the 'Units') at a price of USD $0.50 per Unit for gross proceeds of up to USD $400,000 (the 'Offering'). Each Unit will consist of one common share in the capital of the Company (a 'Share') and one transferable common share purchase warrant (a 'Warrant'), with each warrant exercisable into one additional share at a price of USD $1.00 for a period of three years from the date of closing (subject to acceleration in certain circumstances). Read this and more news for Vinergy Resources at:http://www.marketnewsupdates.com/news/vnnyf.html
Vinergy Resources recently announced that it has signed a definitive agreement with 1099955 B.C. LTD. dba MJ BioPharma ('MJ BioPharma') whereby Vinergy will purchase 100% of MJ BioPharma, a cannabis technology company. Pursuant to the terms of the Agreement, the Company will acquire all of the issued and outstanding securities of MJ BioPharma. MJ Biopharma is a cannabis technology company with a team of experienced business and medical professionals, biochemists and researchers.
In conjunction with acquisition of MJ Biopharma, the Company announced it has developed a disruptive solvent-based extraction system. The project currently underway for an existing customer, utilizes an ethanol / CO2 co-solvent blend and specialized equipment to achieve medicinal products with significantly increased purity. The current iteration of the machine has the physical footprint of a standard shipping skid and incorporates safety and process control systems in one easy-to-use platform.
In other industry news and market performance of note in the sector:
Terra Tech Corp. (OTCQX: TRTC) closed up on Monday at $0.197 trading over 2.5 million shares by the market close. Terra Tech Corp last week announced its first quarter 2017 financial results for the period ended March 31, 2017. Derek Peterson, Chief Executive Officer of Terra Tech Corp., commented, "We are pleased to see the impact of our expansion strategy to open cannabis dispensaries in core target markets drive strong sales in the first quarter. We also reported higher sales of our wholesale IVXX-branded cannabis products as a result of its improved brand recognition coupled with expanded distribution channels. Total first quarter revenues were $6.8 million, representing a 340% increase over the prior year period and we are on track to meet our revenue guidance of $38 - $40 million for 2017."
mCig, Inc. (OTCQB: MCIG) closed up over 5% on Monday at $0.2425 trading over 3.4 million shares by the market close. mCig, Inc. yesterday announced some highlights of its year-end financial results: Net Sales increased to $4.5 million, a 158% increase year-to-year comparison, and a 1,294% increase for the 4th quarter compared to same period last fiscal year - Net income of $1.5 million compared to a $1.4 million loss from the previous year, and an increase of $2.9 million net earnings - Cash and cash equivalents of $1.6 million compared to $0.1 million from the previous year (a 1,369% increase), and a 400% increase from last quarter. mCig generated $2.1 million in cash from operating activities - mCig assets increased to $6.8 million, having 6 times more assets than it does liabilities. In addition to the highlights mentioned above, mCig Inc. was able to reduce its operating expenses by $730K (43%) from the previous year. In addition, mCig increased its gross profit by 20% to 36% compared to 16% from the previous year.
Radient Technologies Inc. (TSX-V: RTI.V) (OTC: RDDTF) closed up over 16% at $0.56 on Monday trading over 3.6 Million shares on the Canadian TSX Venture exchange by the market close. Radient Technologies announced yesterday the completion of the second phase of its previously announced joint venture research agreement with Aurora Cannabis Inc. (TSX-V: ACB. V)(OTCQX ACBFF). As previously announced, Radient and Aurora entered into a memorandum of understanding ('MOU') with regard to the exclusive joint development and commercialization of superior and standardized cannabinoid extracts for the Canadian market. In accordance with the MOU, the parties entered into a joint venture research agreement to confirm the effectiveness of Radient's MAP™ technology for cannabis extraction.
http://marijuanastocks.com/vnnyf-announces-usd-200000-private-placement/
$VNNYF Announces $200,000 Above-Market Private Placement
This Represents A Premium Of 46% To Wednesday’s (5-10) Closing Price & More Than 200% Premium To The Prior Round Of Financing Done By The Company
Vinergy Resources Ltd. (“Vinergy” or the “Company”) (CSE:VIN) (VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 400,000 units (the “Units“) at a price of USD $0.50 per Unit for gross proceeds of up to USD $200,000 (the “Offering“). Each Unit will consist of one common share in the capital of the Company (a “Share“) and one transferable common share purchase warrant (a “Warrant“), with each Warrant exercisable into one additional Share at a price of USD $1.00 for a period of three years from the date of closing (subject to acceleration in certain circumstances).
In connection with the Offering, the Company may pay a finder’s fee on the Offering within the amount permitted by the policies of the Canadian Securities Exchange (the “Exchange”).
Closing of the Offering is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the Exchange. All securities issued in connection with the Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. The Offering is not subject to a minimum aggregate amount of subscriptions.
PP 50 cents US
http://www.marketwired.com/press-release/vinergy-resources-announces-usd-200000-private-placement-cse-vin-2215699.htm
Vinergy Resources Announces USD $200,000 Private Placement
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 11, 2017) - Vinergy Resources Ltd. ("Vinergy" or the "Company") (CSE:VIN) (OTCQB:VNNYF) in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 400,000 units (the "Units") at a price of USD $0.50 per Unit for gross proceeds of up to USD $200,000 (the "Offering"). Each Unit will consist of one common share in the capital of the Company (a "Share") and one transferable common share purchase warrant (a "Warrant"), with each Warrant exercisable into one additional Share at a price of USD $1.00 for a period of three years from the date of closing (subject to acceleration in certain circumstances).
In connection with the Offering, the Company may pay a finder's fee on the Offering within the amount permitted by the policies of the Canadian Securities Exchange (the "Exchange").
It’s A Done Deal! VNNYF to Acquire Cannabis Biopharma Tech Company! What Does This Mean?
http://marijuanastocks.com/its-a-done-deal-vnnyf-to-acquire-cannabis-biopharma-tech-company-whats-this-mean/
It’s a Done Deal! Just as we had suspected, Vinergy Resources (VNNYF) today announced the signing of a definitive agreement to acquire 100% of MJ Biopharma, a cannabis technology company. We have been speculating for over a week that the halt of trading on the Canadian exchange for symbol VIN.CN was to allow for this completed acquisition, and we were right. The stock has gained as much as 36% since we re-initiated coverage on VNNYF last week in anticipation of this deal closing. But now the real fun begins…
This is a major milestone for VNNYF and its shareholders that gives a true fundamental boost to the company. The investment community has been waiting for closure on this item for some time now dating back months ago when the company first mentioned its plans for the acquisition. Back then Vinergy’s stock skyrocketed on the possibility of the deal closing but soon pulled back as investors perhaps grew tired of waiting for a definitive deal, or maybe they doubted the whole deal altogether.
Well, now today’s news from VNNYF of a signed definitive agreement will put all that uncertainty and impatience to rest while sparking a new level of interest and excitement.
Incentivized Compensation Plan
Perhaps the most exciting piece of this acquisition is the means in which Vinergy is acquiring MJ Biopharma. 4.25M shares of common stock priced at $0.20CAD are to be issued upfront, 2/3 of which will be held in escrow. But MJ Biopharma management and shareholders have the opportunity to earn an additional 5M shares is they bring each of their 4 product segments to commercialization. This is a genius move by VNNYF management that could drastically increase shareholder value down the road.
What is VNNYF Acquiring?
MJ Biopharma is a cannabis technology company with a team of experienced business and medical professionals, biochemists and researchers. The company is currently focused on the following areas of interest:
manufacturing breath strips;
time release capsules;
extract oils;
food products and infused juices, teas, coffee and extract drinks;
pharmaceutical grade delivery systems;
MJ Biopharma’s expertise lies in its extracts and custom formulations. The company will also aim to inlicense and joint venture on best in class technologies and products for both the medicinal and recreational markets – domestically and internationally.
The Big Picture is Starting to Come Together
The company said their novel approach for its breath strip technology may become the basis for new products where water or saliva is the catalyst to activate the carrier for delivery and absorption of CBD into the body. Management believes this breakthrough could form the basis of a new technology and has the potential to create an entirely new product category. The technology is called BURST, named for the speed at which it enhances the body’s absorption of various ingredients.
And let’s not forget that VNNYF signed a binding letter of intent to acquire 65% of Biolennia Laboratories. Biolennia Labs is a specialty development laboratory with expertise in microbiology and chemistry. The lab operates out of a secure facility in Toronto alongside Micrylium, which manufactures products registered under license from several agencies. It currently provides testing, R&D, and quality control for Health Canada registered and approved industrial disinfectants and other consumer products on behalf of Micrylium.
Vinergy also reported the development of a disruptive solvent-based extraction system. The project is already underway and the company will be providing updates and more information soon. Positive results from this project could be another strong catalyst for VNNYF. And with the acquisition of MJ Biopharma finally completed, all the pieces appear to be falling perfectly into place.
What was once speculation and hype that ignited nearly a 200% move in Vinergy’s stock months ago when this acquisition was just a “possibility” has just officially become reality. The structure of this deal and the current market conditions could present great opportunity for VNNYF shareholders. So far we have seen VNNYF gain as much as 36% since we re-initiated coverage on the company but with this acquisition finally in the books, this could be just the beginning.
Well you can by in the US VNNYF !!
Major Acquisition Closes
https://technical420.com/cannabis-article/biotech-earnings-updates-and-major-acquisition-closes
This morning, Vinergy Resources Ltd. (VIN.CN: CSE) (VNNYF: OTCQB) reported the signing of a definitive agreement to complete the acquisition of MJ BioPharma. This acquisition was initially reported in mid-December and we expect to see the market favorably respond.
MJ Biopharma is a private cannabis technology company based out of British Columbia that is currently focused on manufacturing breath strips, time release capsules, extract oils, food products such as infused teas, coffee, juices and other drinks, as well as the development of pharmaceutical grade delivery systems. The company will also aim to in-license and joint venture on technologies and products for global medical and recreational cannabis industry.
The closure of this deal is something to watch as it will allow the companies to scale and form synergies to increase value for shareholders. We expect the acquisition to be very accretive with numerous synergies for the company as Vinergy has significantly advanced its business after it initially announced the acquisition.
These 5 Public Companies May See Growth from Advanced Extraction for High Quality CBD Oil
http://theseedinvestor.com/marijuana-investing/advanced-extraction-methods-leading-to-high-quality-cbd-products-and-revenue-growth-potential
Advancements continue to be made in various CBD extractions as the demand for cannabis extracts continues to climb at a high rate. Cannabidiol (CBD) is one of the most important healing substances, with a strong anti-inflammatory effect and without a psychotropic (narcotic) effect.
These are the companies with the most revenue growth potential.
?Vinergy Resources Ltd. (OTCQB:VNNYF, CSE:VIN.CN), in conjunction with its proposed acquisition of MJ Biopharma (announced December 14, 2016), is pleased to announce it has developed a disruptive solvent based extraction system.
The project currently underway for an existing customer, utilizes an ethanol / CO2 co-solvent blend and specialized equipment, to achieve medicinal products with significantly increased purity. The current iteration of the machine has the physical footprint of a standard shipping skid and incorporates safety and process control systems, in one easy-to-use platform.
Breaking News | Vinergy Resources (VNNYF) Signs Definitive Agreement to Acquire MJ BioPharma
http://marijuanastocks.com/vinergy-resources-signs-definitive-agreement-to-acquire-mj-biopharma/
$VNNYF Makes Yet Another New High
That’s right, another big day for Vinergy Resources (VNNYF); hitting brand new weekly highs. This week’s action has definitely got our attention. We re-initiated coverage of this company on May 1, 2017, at $0.33 and in just four days we have already seen a record setting volume day TWICE and a steady 36% climb.
On May 4th, VNNYF made a new 4-day high of $0.45 on well-above-average volume. And the quick test of support could be just the slight consolidation many were waiting to see before another run for this marijuana stock.
To get up to speed on Vinergy’s MJBiopharma transaction, read this article to see what investors should know about the pending acquisition of MJ Biopharma:
The Significance of the MJ Biopharma Acquisition – What Investors Should Know
http://marijuanastocks.com/vinnyf-marijuana-stocks-update/
As most of you already know, trading of Vinergy on the Canadian stock exchange under symbol VIN.CN has been halted pending a fundamental change in the company. It is our opinion and assumption that this ‘fundamental change’ could be the completion of the MJ Biopharma acquisition that the company mentioned months ago. We cannot be certain of this, but there is a lot of buzz circulating right now about this potential acquisition and the recent trading activity on the U.S. side in VNNYF. If you haven’t done so already, familiarize yourself with Vinergy Resources (VNNYF) and MJ Biopharma because if this acquisition is completed, the most informed investors will be in the best position.
VNNYF Largest Volume Day Ever…Again!
http://marijuanastocks.com/marijuana-stock-vnnyf-largest-volume-day-ever-again/
Wow, another record volume day for Vinergy Resources (VNNYF). This action has definitely got our attention. We re-initiated coverage of this company on May 1, 2017, at $0.33 and in just three days we have already seen a record setting volume day TWICE and a steady 27% climb.
Today, May 3rd, VNNYF made a new 3-day high of $0.42 on record volume. We are getting a lot of messages from subscribers asking about what the acquisition of MJ Biopharma could mean for Vinergy and its shareholders. To get up to speed, read this article to see what investors should know about the pending acquisition of MJ Biopharma:
The Significance of the MJ Biopharma Acquisition – What Investors Should Know
As most of you already know, trading of Vinergy on the Canadian stock exchange under symbol VIN.CN has been halted pending a fundamental change in the company. It is our opinion and assumption that this ‘fundamental change’ could be the completion of the MJ Biopharma acquisition that the company mentioned months ago. We cannot be certain of this, but there is a lot of buzz circulating right now about this potential acquisition and the recent trading activity on the U.S. side in VNNYF. If you haven’t done so already, familiarize yourself with Vinergy Resources (VNNYF) and MJ Biopharma. Because if this acquisition is completed, the most informed investors will be in the best positio
Marijuana Stocks from Canada You Need to Be Watching
http://www.huffingtonpost.com/entry/marijuana-stocks-from-canada-you-need-to-be-watching_us_590a1612e4b03b105b44be84
Vinergy Resources (OTC:VNNYF) – Market Cap $23.7M
Vinergy Resources focuses on Canada’s emerging medical and recreational marijuana industry. Through a proposed acquisition of MJ Biopharma, the next stage for company growth has also targeted new technologies & extraction methods. In February, the company announced key findings while conducting research on oral cannabinoid delivery strips. Essentially, the patent pending technology, called BURST, enhances the body’s absorption of ingredients and could become a drug delivery system that is efficient in enhancing user experiences.
In addition to this, Vinergy has also been developing new extraction methods that could end up shortening the processing cycle and increase the overall production supply while also enhancing product quality. The recent signing of a binding letter of intent to acquire 65% of Biolennia Laboratories could also offer opportunity for the company. Among other things, the major importance of this surrounds Biolennia’s current process of applying for a Dealer’s License from Health Canada. This would allow the company to process cannabis for R&D purposes.
Shorts better cover before the deal is announced LOLOLOL.....Must be close
90 cent bids on CDN side....VIN did hit 1.15 last time. And who knows what they have been working on this whole time.....
Anybody buying better do it now before the clowns cover and deal gets announced.
Shorts do yourself a favor...take the hit asap or you will be shorting your pants..
http://marijuanastocks.com/vinnyf-marijuana-stocks-update/
http://marijuanastocks.com/best-marjuana-stocks-vnnyf-update2/
Hmmm I smell a short squeeze coming..... Run rabbit run.... Clock just started yesterday imo...
It's going to be explosive....
Nice form 9 you have there, notice all those big 100K-135k lots ( I count 10) it's all friends and family.... All have been contacted and all not selling a share. So 75% of PP in very safe hands.
+ Canadians can't sell now so you shorts better cover ASAP !!
Oh and look at OTCQB: LDSYF volume and spike (32m market cap) vs our VNNYF aka the real deal... Look at RTI 76m market cap...
Oh I see big 90 cent bids on VNNYF canadian market VIN....
SHORTS BETTER COVER !!!
Bids currently 75 cents on the Canadian market
Wold calling for 55 cents next week: https://twitter.com/WolfOfWeedST/status/859773437732167681
$VNNYF Continues To Trend Higher
http://marijuanastocks.com/best-marjuana-stocks-vnnyf-update2/
Another strong day in the books for Vinergy Resources (VNNYF) as the stock gained 11% today, May 2, 2017. With this type of action, everyone should be starting to take notice and paying attention. Volume was again at record levels which could be signaling that investors are starting to act ahead of the possible completed acquisition of MJ Biopharma. VNNYF has now gained 23% since we re-initiated coverage on the company just two days ago.
As we pointed out earlier, trading for Vinergy Resources on the Canadian exchange under symbol VIN.CN has been halted pending a fundamental change in the company. Through corporate announcements and pure logic it is our assumption that the fundamental change is the completion of the MJ Biopharma acquisition. The hype and speculation that helped skyrocket Vinergy’s stock nearly 200% earlier this year (when we first initiated coverage on the company), could finally be coming to fruition. The hype that drove investors wild just a few months ago could soon be reality.
While trading of Vinergy in Canada under VIN.CN is halted, trading on the U.S. exchange through symbol VNNYF is picking up in a huge way. We have seen record volume days this week and a consistent, steady climb in share price. It would appear that momentum is in our favor as speculation once again starts to swirl around chat rooms and message boards about what the MJ Biopharma acquisition could mean for VNNYF and its shareholders. For more on why it’s significant and what investors should know about the acquisition, click here. http://marijuanastocks.com/vinnyf-marijuana-stocks-update/
What a Scientific Advisory Board Addition Means for the Company’s Cannabis Initiative
Vinergy recently made a jaw dropping addition to their Scientific Advisory Board that seems to be in line with an MJ Biopharma acquisition. The company recently added John Simon, a senior member of the American Society for Quality, a certified quality auditor and registered quality assurance professional. Mr. Simon has been directly involved with FDA and Health Canada audits of drug manufacturers, testing facilities, and clinical sites.
Simon assists companies with both site and product licenses. He has helped several companies obtain, renew, and maintain in good standing Drug Establishment Licenses, Medical Device Establishment Licenses, Natural and Non-prescription Site Licenses, and Licenses to Cultivate and Distribute under the Marihuana for medical Purposes Regulations (MMPR which is now under the ACMPR).
He has extensive experience when it comes to product submissions to both the FDA and Health Canada. Simon will play a key role in driving the company’s cannabis product and technology initiatives. His work could be critical to MJ Biopharma’s long-term strategy of conducting studies out of a state-of-the-art lab focused on identifying specific cannabinoid isolates for targeted therapeutic purposes.
John Simon could be VNNYF’s bridge to the FDA and Health Canada hopefully ensuring a smooth approval and licensing process for the company. We could be speculating here a bit but it certainly seems like the addition of John Simon was carefully calculated by management and could return tremendous value for the company.
Vinergy Resources (VNNYF) Update... Continues To Trend Higher
Another strong day in the books for Vinergy Resources (VNNYF) as the stock gained 11% today, May 2, 2017. With this type of action, everyone should be starting to take notice and paying attention. Volume was again at record levels which could be signaling that investors are starting to act ahead of the possible completed acquisition of MJ Biopharma. VNNYF has now gained 23% since we re-initiated coverage on the company just two days ago.
FULL UPDATE
Looks like a done deal...lucky Americans can buy...Canadians have to wait for halt to be removes,,, :(
The Significance of the MJ Biopharma Acquisition – What Investors Should Know
Today May 1, 2017, Vinergy Resources (VNNYF) gained as much as 18% as we re-initiated coverage on the company pending their proposed acquisition of MJ Biopharma. Today also marked the highest volume day ever for the stock as it appears investors are beginning to recognize the significance of the acquisition and what it could mean for the future of this company.
The last time we covered Vinergy was back on December 30, 2016, when it only traded on the Canadian market under symbol VIN.CN. At that time we saw the stock gain 191% in just over 1 month climbing from $0.395 to $1.15 CAD. Since then, Vinergy has begun trading in the U.S. under VNNYF and we believe it could be time for you to start paying attention to the company once again. And today’s price movement could add to our conviction.
Earlier this year in late March, trading of VIN.CN was halted on the Canadian exchange due to an upcoming fundamental change in the company. This is NOT a regulatory suspension. It is a halt initiated by the exchange because of an upcoming fundamental change in the company. We assume that this is because of the pending acquisition of MJ Biopharma.
But, while trading in Canada is put on pause, trading on the U.S. exchange through ticker symbol VNNYF continues to roar on. We believe this could be a rare opportunity to take advantage of a pending fundamental change in the company while shares of the Canadian listing are halted. Earlier this year, many of our U.S. subscribers without global trading access sat and watched Vinergy stock skyrocket on the Canadian exchange after we published an article on December 30, 2016, naming Vinergy as one of the top marijuana stocks to watch in 2017. For those who missed the first rally (and those who were able to profit handsomely from it), pay close attention to what you’re about to read next…
The Significance of the MJ Biopharma Acquisition – What Investors Should Know
MJ Biopharma is a private cannabis technology company based out of British Columbia that is currently focused on manufacturing breath strips, time release capsules, extract oils, food products such as infused teas, coffee, juices and other drinks, as well as the development of pharmaceutical grade delivery systems. They also focus on licensing and partnering on the development of technologies and products for the medical and recreational cannabis market in Canada and abroad.
Compensation Structure
But what makes this acquisition unique and one of the main points that caught our attention about the deal between the two companies, is the milestone based compensation. Vinergy is issuing 5 million shares of its common stock to the current shareholders of MJ Biopharma with an additional 3.75 million shares to be issued following the completion of certain milestones.
Vinergy will issue 2.75 million shares upon the commercialization of MJ Biopharma’s strip technology.
The company will issue 1 million shares when each of the two alternative selected extractions/products are ready for commercialization.
The shares will be subject to escrow conditions and/or resale restrictions as required by applicable securities laws and the policies of the Canadian Stock Exchange. This is a genius move by VNNYF and should be music to the ears of all VNNYF shareholders. This incentivizes MJ Biopharma to progress and succeed on their business plan which will bring even greater value to VNNYF and its shareholders.
Breakthrough in CBD Strips and Capsules
In February, VNNYF announced a breakthrough while conducting research & development on its oral cannabinoid delivery strips and controlled time release capsule technology. The company said the novel approach under development may become the basis for new products where water or saliva is the catalyst to activate the carrier for delivery and absorption of CBD into the body.
Management believes this breakthrough could form the basis of a new technology and has the potential to create an entirely new product category. The technology is called BURST, named for the speed at which it enhances the body’s absorption of various ingredients. The BURST technology is built around natural botanical polymers delivering specialty processed high purity cannabinoids. The patent pending technology allows for a more complete palatable drug delivery system that is effective and enhances patient or user experience and can intensify flavors.
Expanding Their CBD Extract Business
February was a busy month for Vinergy as they also announced a memorandum of understanding with Namaste Technologies to commercialize proprietary CBD extract formulations through Namaste’s retail websites in the United States. Namaste has approximately 300,000 customers who visit the company’s website more than 600,000 times a month. Vinergy will be distributing its proprietary formulations to Namaste’s monthly unique visitors.
Acquire 65% of Specialty Laboratory Applying for a Dealer’s License
Again, in late February, VNNYF signed a binding letter of intent to acquire 65% of Biolennia Laboratories. Biolennia Labs is a specialty development laboratory with expertise in microbiology and chemistry. The lab operates out of a secure facility in Toronto alongside Micrylium, which manufactures products registered under license from several agencies. It currently provides testing, R&D, and quality control for Health Canada registered and approved industrial disinfectants and other consumer products on behalf of Micrylium.
Biolennia is in the process of applying for a Dealer’s License from Health Canada which would let the company process cannabis for R&D purposes. Receipt of this license would be a major fundamental accomplishment for the company. Biolennia has in-house expertise when it comes to the methods accepted by both Health Canada and the FDA for determining the purity and quality involved in validating cannabis and testing cannabis products.
State-of-the-Art Extraction System
Moving on to March, VNNYF reported the development of a disruptive solvent-based extraction system. The project is already underway and the company will be providing updates and more information soon. Positive results from this project could be another strong catalyst for VNNYF.
The extraction system’s proprietary technology utilizes a blend of ethanol and CO2 co-solvent and specialized equipment to shorten the processing cycle, and increase the average production yield while also improving product quality. MJ Biopharma’s CEO said the system has been tested to work with other solvent blends and may be able to produce end products like terpenes, which would add IMMEDIATE value to the company.
The Reality of It All
When we first initiated coverage on Vinergy Resources in December 2016, the market strongly agreed with us as we saw the stock gain nearly 200% in just over a month. Since then, Vinergy has begun trading in the U.S. through ticker symbol VNNYF and trading of the Canadian ticker VIN.CN has been halted pending a fundamental change in the company. And based on company announcements and pure logic, we believe this halt is for the completed acquisition of MJ Biopharma.
Following the rally we saw in Vinergy stock earlier this year, shares have pulled in in recent months. Whether the pull in is just profit taking from people who were already up +100% on their positions or for some other reason, the current market conditions could be presenting a unique opportunity for investors to capitalize on a company that has had its stock halted pending a fundamental development. It is very possible that once trading resumes on the Canadian stock exchange for Vinergy that we see an increase in investor interest with the acquisition finally being complete.
If the halt is indeed to allow for the completed acquisition of MJ Biopharma, what was once speculation and hype on possibility is now becoming reality. And if Vinergy stock soared nearly 200% just based on the potential ‘what ifs’ of an acquisition, what do you think will happen when ‘what if’ becomes ‘what’s next’?
Mark it.. $vnnyf will break out in 30 days will be 30%+ higher
Mark it.. $vnnyf will break out in 30 days will be 30%+ higher 🕵💰🚀🐺 pic.twitter.com/fD8fpdDGG4
— Jason Spatafora (@WolfOfWeedST) May 1, 2017
From marijuana stocks:
$VNNYF is back on our radar in a BIG WAY
$VNNYF is back on our radar in a BIG WAY https://t.co/CdwBdRcfzJ @WolfOfWeedST @Technical420 #marijuana #marijuanastocks #pot #PotStocks
— Marijuana Stocks (@MarijuanaStocks) May 1, 2017
Namaste Signs Services Agreement with Canopy Growth Corporation
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 20, 2017) - Namaste Technologies Inc. ("Namaste" or the "Company") (CSE:N)(CSE:N.CN)(FRANKFURT:M5BQ)(OTCQB:NXTTF) is pleased to announce that, building on a previously announced MOU, the Company has entered into a services agreement (the "Agreement") with Canopy Growth Corporation ("Canopy"). This Agreement represents the execution of Namaste's strategic objective to actively migrate medical cannabis consumers to a licensed producer. Namaste's database consists of approximately 300,000 customers that generate upwards of 600,000 site visits monthly. Approximately 28,000 of these monthly site visits are generated from customers residing in Canada.
The purpose of the Agreement is to outline the responsibilities of each of Namaste and Canopy with respect to the provision of education and awareness regarding safe and legal access to medical cannabis. Namaste's responsibilities include, but not are limited to: providing information on its websites and blogs outlining how to obtain medical cannabis from legal licensed producers including details on what is legally required under the Access to Cannabis for Medical Purposes Regulations.
Management Commentary
Sean Dollinger, President and CEO of Namaste, comments: "Our Company has successfully built one of the largest and most global client relationship databases in the cannabis industry and we view broadening our strategic alliances to the benefit of our customers and shareholders. Consistent with our strategy to partner with leading companies that hold themselves to the highest standards, Canopy represents the ideal partner for us to roll-out this strategy alongside. Going forward, we see multiple opportunities to expand this strategy globally."
huge things going on with VNNYF...patience and get them while you can
It's time to load up yes... NXTTF
It's time to load up yes... NXTTF
Namaste Is Staging A Strong Comeback
As Canada continues to lead the global cannabis movement the Canadian cannabis industry presents some of the most attractive investment opportunities.
This growth has benefited hundreds of companies levered to the cannabis industry and we want to highlight a company that so far this year has shown vast improvements.
That company is Namaste Technologies (N.CN) (NXTTF: OTCQB), an emerging leader in the vaporizer and accessories industry. Namaste has 26 e-commerce retail stores in 20 countries and is actively manufacturing and launching multiple unique proprietary products for retail and wholesale distribution. Namaste has recently focused on expanding its product offering, acquisitions and strategic partnerships, and entering new international markets.
Namaste started the month of March on a strong note when it significantly improved its standing with United States investors as it was approved to list on the OTCQB with Canaccord Genuity as a market maker.
Continues to Execute on Business Initiatives
Last week, Namaste entered a non-binding letter of intent to purchase all issued and outstanding shares of Cannmart Inc., a late stage applicant under the ACMPR. In 2014, CannMart submitted its application to become a sales only licensed medical cannabis producer
CannMart’s application is currently in the review stage of the licensing process and the company applied to sell (not produce) medical cannabis. Under this model and subject to obtaining a license from Health Canada, CannMart can purchase wholesale product from other licensed producers and sell to individual patients in accordance with the ACMPR.
The deal is a big development for Namaste as it takes place before recreational cannabis legislation is introduced in Canada. The company’s rationale for the deal is:
Upon execution of the letter of intent, Namaste paid $50,000 to CannMart's counsel, to be held in trust and released upon closing of the deal. If Namastedoes not provide CannMart with notice of completion of its due diligence within 30 days of the execution of the letter of intent, the $50,000 becomes non-refundable. The companies expect to sign a definitive agreement in mid-late April.
Increases Market Share In Australia
Earlier this month, Namaste completed the acquisition of Australian Vaporizers with the proceeds from the bought deal that closed on March 9th (completed a financing of CAD $11,338,000).
We expect this acquisition to quickly prove to be accretive as Australian Vaporizers adds a new revenue stream and further solidifies Namaste as one of the largest online vaporizer retailers in the world. Namaste will now control approximately 90% of the vaporizer online retail market in Australia.
Australian Vaporizers significantly improves Namaste’s balance sheet and cash flow statement as it will immediately increase the company’s total revenue by 33%.
Namaste also recently announced a memorandum of understanding with Vinergy Resources (VIN) (VNNYF) to commercialize proprietary CBD extract formulations through Namaste’s retail websites in the United States.
Integrates EveryoneDoesIt and eBay into E-Commerce Activities
Namaste recently released an update on its ecommerce activities including the integration of the EveryoneDoesIt platforms and eBay marketplace regarding optimizing the commercial potential of these platforms. The company reported substantial progress.
Namaste successfully migrated the EveryoneDoesIt portals to its Shopify platform and improved the overall customer experience by revamping the user interface. The company's e-commerce team also created and implemented a platform that will allow them to access and seamlessly update all product listings and website characteristics across multiple Shopify storefronts.
Namaste received approval to list over 100 products for distribution though eBay Inc. The Company plans to list over 1,000 products for sale, including the latest vaporizers and accessories. Due to eBay’s large customer base and the fact Namaste is one of the only companies to be approved for the distribution of vaporizers through eBay, its product sales and revenue generation will increase significantly as it continues to add products for distribution. This is the first full month of having listings live for purchase on eBay.
An Improving Fundamental Outlook
Namaste has been able successfully to execute on its business plan and we expect these developments benefit the shareholder significantly over the next year. Recent changes will have a major impact on the company as it will significantly improve overall fundamentals through the addition of new revenue streams and improved operational efficiencies.
Although the last month has been significant for the company, the shares have been trending lower and we believe this is a stock investors need to watch.
Canada To Announce Legislation Next Month
Week of April 10th !!
CBC News has learned that the legislation will be announced during the week of April 10 and will broadly follow the recommendation of a federally appointed task force that was chaired by former liberal Justice Minister Anne McLellan.
http://www.cbc.ca/news/politics/liberal-legal-marijuana-pot-1.4041902
Canada To Announce Legislation Next Month
Week of April 10th !!
CBC News has learned that the legislation will be announced during the week of April 10 and will broadly follow the recommendation of a federally appointed task force that was chaired by former liberal Justice Minister Anne McLellan.
http://www.cbc.ca/news/politics/liberal-legal-marijuana-pot-1.4041902
https://technical420.com/cannabis-article/10-company-insights-you-need-know
The cannabis sector continues to be the fastest growing industry in the world and it continues to provide investors will ample opportunities.
The high-growth nature of this industry can be challenging at times and this is primarily the result of the breadth of opportunities and lack of information about them.
We want to simplify the cannabis investing process by highlighting the nine most important cannabis developments to hit the newswire this week.
Namaste Technologies (N.CN) (NXTTF) entered a non-binding letter of intent with Cannmart Inc., a late stage applicant under the ACMPR. Namaste will purchase all issued and outstanding shares. In 2014, CannMart submitted its application to become a sales only licensed medical cannabis producer.